Treatment of peyronie’s disease with combination of clostridium histolyticum collagenase and penile traction therapy: a prospective, multicenter, single-arm study

2020 ◽  
Author(s):  
Borja García-Gómez ◽  
Esther García-Rojo ◽  
Manuel Alonso-Isa ◽  
José Medina-Polo ◽  
Rocío Santos-Pérez de la Blanca ◽  
...  
Keyword(s):  
Peyronie’S Disease ◽  
Clostridium Histolyticum ◽  
Clostridium Histolyticum Collagenase ◽  
Peyronie's Disease

Analysis of our results in the treatment of Peyronie’s disease with Clostridium histolyticum collagenase and modeling using penis extender

2018 ◽  
Vol 17 (2) ◽  
pp. e1693
Author(s):  
M. Alonso Isa ◽  
B. García-Gómez ◽  
J. Medina-Polo ◽  
J. Justo-Quintas ◽  
E. García-Rojo ◽  
...  
Keyword(s):  
Peyronie’S Disease ◽  
Clostridium Histolyticum ◽  
Clostridium Histolyticum Collagenase ◽  
Peyronie's Disease

scholarly journals Intralesional collagenase Clostridium histolyticum in the management of Peyronie’s disease: current best practice

2018 ◽  
Vol 10 (4) ◽  
pp. 139-153 ◽  
Author(s):  
Daniel J. Cwikla ◽  
Faysal A. Yafi
Keyword(s):  
Best Practice ◽  
Peyronie’S Disease ◽  
Injection Technique ◽  
Intralesional Injection ◽  
Collagenase Clostridium Histolyticum ◽  
Safety And Efficacy ◽  
Clostridium Histolyticum ◽  
Clostridium Histolyticum Collagenase ◽  
Peyronie's Disease

The use of Clostridium histolyticum collagenase (CCH) has become increasingly widespread for the treatment of Peyronie’s disease (PD) in recent years. Numerous trials have confirmed both its safety and efficacy in appropriately selected patients with this condition. The purpose of this review is to examine pivotal trials demonstrating the efficacy of CCH, revisit viable candidates for treatment with intralesional injection therapy, and provide a summary of injection technique and appropriate management of patients receiving this treatment at the time of therapy and in follow up.

Sign in / Sign up

Export Citation Format

Share Document